Cost-effectiveness of medical management strategies for nephrolithiasis

Journal of Urology

Volumn 172, Issue 6 I, 2004, Pages 2275-2281

  Lotan, Yair ^a   Cadeddu, Jeffrey A ^a   Roerhborn, Claus G ^a   Pak, Charles Y C ^b   Pearle, Margaret S ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cost benefit analysis; Drug therapy; Urinary calculi

Indexed keywords

CITRATE POTASSIUM; HYDROCHLOROTHIAZIDE;

ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DIET THERAPY; DRUG COST; EMERGENCY TREATMENT; EMERGENCY WARD; HOSPITAL COST; HUMAN; MEDICAL ASSESSMENT; METABOLISM; NEPHROLITHIASIS; PHARMACY; PRIORITY JOURNAL; RECURRENT DISEASE; RISK REDUCTION; SENSITIVITY ANALYSIS; THEORETICAL MODEL; TREATMENT OUTCOME;

EID: 8644265232     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000141498.11720.20     Document Type: Article

References (43)

1. Clark, J. Y., Thompson, I. and Optenberg, S. A.: Economic impact of urolithiasis in the United States. J Urol, 154: 2020, 1995
2. Pearle, M. S., Roehrborn, C. G. and Pak, C. Y.: Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. J Endourol, 13: 679, 1999
3. Ettinger, B., Pak, C. Y. C., Citron, J. T., Thomas, C., Adams-Huet, B. and Vangessel, A.: Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol, 158: 2069, 1997
4. Pak, C. Y. C., Peterson, R. and Poindexter, J. R.: Adequacy of a single stone risk analysis in the medical evaluation of urolithiasis. J Urol, 165: 378, 2001
5. Yagisawa, T., Chandhoke, P. S. and Fan, J.: Comparison of comprehensive and limited metabolic evaluations in the treatment of patients with recurrent calcium urolithiasis. J Urol, 161: 1449, 1999
6. Pak, C. Y.: Southwestern Internal Medicine Conference: medical management of nephrolithiasis - a new, simplified approach for general practice. Am J Med Sci, 313: 215, 1997
7. Barcelo, P., Wuhl, O., Servitge, E., Rousaud, A. and Pak, C. Y. C.: Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol, 150: 1761, 1993
8. Chandhoke, P. S.: When is medical prophylaxis cost-effective for recurrent calcium stones? J Urol, 168: 937, 2002
9. Tiselius, H.-G.: Comprehensive metabolic evaluation of stone formers is cost-effective. In: Urolithiasis 2000: Proceedings of the 9th International Symposium on Urolithiasis. Edited by A. L. Rodgers, B. E. Hibbert, B. Hess, S. R. Khan and G. M. Preminger. Cape Town, South Africa: University of Cape Town Press, pp. 349-355, 2000
10. Parks, J. H. and Coe, F. L.: The financial effects of kidney stone prevention. Kidney Int, 50: 1706, 1996
11. Robertson, W. G.: The economic case for the biochemical screening of stone patients. In: Urolithiasis 2000: Proceedings of the 9th International Symposium on Urolithiasis. Cape Town, South Africa: University of Cape Town Press, pp. 403-405, 2000
12. Strohmaier, W. L. and Hörmann, M.: Economic aspects of urolithiasis (u) and metaphylaxis (x) in Germany. In: Urolithiasis 2000: Proceedings of the 9th International Symposium on Urolithiasis. Cape Town, South Africa: University of Cape Town Press, pp. 406-409, 2000
13. Glowacki, L. S., Beecroft, M. L., Cook, R. J., Pahl, D. and Churchill, D. N.: The natural history of asymptomatic urolithiasis. J Urol, 147: 319, 1992
14. Keeley, F. X., Jr., Tilling, K., Elves, A., Menezes, P., Wills, M., Rao, N. et al: Preliminary results of a randomized controlled trial of prophylactic shock wave lithotripsy for small asymptomatic renal calyceal stones. BJU Int, 87: 1, 2001
15. Streem, S. B., Yost, A. and Mascha, E.: Clinical implications of clinically insignificant store fragments after extracorporeal shock wave lithotripsy. J Urol, 155: 1186, 1996
16. Trinchieri, A., Ostini, F., Nespoli, R., Rovera, F., Montanari, E. and Zanetti, G.: A prospective study of recurrence rate and risk factors for recurrence after a first renal stone. J Urol, 162: 27, 1999
17. Ohkawa, M., Tokunaga, S., Nakashima, T., Orito, M. and Hisazumi, H.: Thiazide treatment for calcium urolithiasis in patients with idiopathic hypercalciuria. Br J Urol, 69: 571, 1992
18. Borghi, L., Meschi, T., Guerra, A. and Novarini, A.: Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. J Cardiovasc Pharmacol, suppl., 22: S78, 1993
19. Wilson, D. R., Strauss, A. L. and Manuel, M. A.: Comparison of medical treatments for the prevention of recurrent calcium nephrolithiasis. Urol Res, 12: 39, 1984
20. Robertson, W. G., Peacock, M. and Selby, P. L.: A multicenter trial to evaluate three treatments for idiopathic calcium stone disease: a preliminary report. In: Urolithiasis and Related Clinical Research. Edited by P. O. Schwille, L. H. Smith, W. G. Robertson and W. Vahlensieck. New York: Plenum Press, pp. 545-548, 1985
21. Scholz, D., Schwille, P. O. and Sigel, A.: Double-blind study with thiazide in recurrent calcium lithiasis. J Urol, 128: 903, 1982
22. Brocks, P., Dahl, C., Wolf, H. and Transbol, I.: Do thiazides prevent recurrent idiopathic renal calcium stones? Lancet, 2: 124, 1981
23. Ettinger, B., Citron, J. T., Livermore, B. and Dolman, L. I.: Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J Urol, 139: 679, 1988
24. Laerum, E. and Larsen, S.: Thiazide prophylaxis of urolithiasis. A double-blind study in general practice. Acta Med Scand, 215: 383, 1984
25. Hofbauer, J., Hobarth, K., Szabo, N. and Marberger, M.: Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis - a prospective randomized study. Br J Urol, 73: 362, 1994
26. Pak, C. Y. C., Skurla, C. and Harvey, J.: Graphic display of urinary risk factors for renal stone formation. J Urol, 134: 867, 1985
27. Pak, C. Y., Kaplan, R., Bone, H., Townsend, J. and Waters, O.: A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias. N Engl J Med, 292: 497, 1975
28. Ljunghall, S. and Danielson, B. G: A prospective study of renal stone recurrences. Br J Urol, 56: 122, 1984
29. Williams, R. E.: Long-term survey of 538 patients with upper urinary tract stone. Br J Urol, 35: 416, 1963
30. Blacklock, N. J.: The pattern of urolithiasis in the Royal Navy. In: Proceedings of the Renal Stone Research Symposium. Edited by A. Hodgkinson and B. E. C. Nordin. London: J. B. A. Churchill, Ltd., chapt. 3, pp. 33-49, 1969
31. Marshall, V., White, R. H., De Saintonge, M. C., Tresidder, G. C. and Blandy, J. P.: The natural history of renal and ureteric calculi. Br J Urol, 47: 117, 1975
32. Ahlstrand, C. and Tiselius, H. G.: Recurrences during a 10-year follow-up after first renal stone episode. Urol Res, 18: 397, 1990
33. Ljunghall, S. and Hedstrand, H.: Epidemiology of renal stones in a middle-aged male population. Acta Med Scand, 197: 439, 1975
34. Strohmaier, W. L., Kellner, T., Lahme, S. and Bichler, H.: The natural history of calcium oxalate urolithiasis in central Europe - course of the disease in first time stone formers without metaphylaxis. In: Urolithiasis 2000: Proceedings of the 9th International Symposium on Urolithiasis. Edited by A. L. Rogers, B. E. Hibbert, S. R. Khan and G. M. Preminger. Cape Town, South Africa: University of Cape Town Press, pp. 369-370, 2000
35. Borghi, L., Meschi, T., Amato, F., Briganti, A., Novarini, A. and Giannini, A.: Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol, 155: 839, 1996
36. Sutherland, J. W., Parks, J. H. and Coe, F. L.: Recurrence after a single renal stone in a community practice. Miner Electrolyte Metab, 11: 267, 1985
37. Johnson, C. M., Wilson, D. M., O'Fallon, W. M., Malek, R. S. and Kurland, L. T.: Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int, 16: 624, 1979
38. Fine, J. K., Pak, C. Y. C. and Preminger, G. M.: Effect of medical management and residual fragments on recurrent stone formation following shock wave lithotripsy. J Urol, 153: 27, 1995
39. Ettinger, B.: Recurrence of nephrolithiasis. A six-year prospective study. Am J Med, 67: 245, 1979
40. Ettinger, B., Tang, A., Citron, J. T., Livermore, B. and Williams, T.: Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med, 315: 1386, 1986
41. Miano, L., Petta, S. and Galatioto, G. P.: A placebo controlled double-blind study of allopurinal in severe recurrent idiopathic renal lithiasis: preliminary results. In: Urolithiasis and Related Clinical Research. Edited by P. O. Schwille, L. H. Smith, W. G. Robertson and W. Vahlensieck. New York: Plenum Press, pp. 521-524, 1985
42. Ettinger, B.: Recurrent nephrolithiasis: natural history and effect of phosphate therapy. A double-blind controlled study. Am J Med, 61: 200, 1976
43. Coe, F. L., Keck, J. and Norton, E. R.: The natural history of calcium urolithiasis. JAMA, 238: 1519, 1977